May 08, 2019 / 09:00PM GMT
Operator
Greetings, and welcome to the Navidea Biopharmaceuticals Q1 2019 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Mr. Jed Latkin, CEO. Thank you, Mr. Latkin. You may begin.
Jed A. Latkin - Navidea Biopharmaceuticals, Inc. - CEO, COO, CFO, Secretary, Treasurer & Director
Good afternoon, and welcome, everyone, to Navidea's First Quarter 2019 Earnings Call. My name is Jed Latkin, and I'm the Chief Executive Officer of Navidea Biopharmaceuticals.
This call will cover Navidea's financial and operating results for the first quarter of 2019 which ended on March 31, 2019, along with a discussion of goals and milestones for the remainder of 2019. Following our prepared remarks, we will open up the conference call to a question-and-answer session. With me on our call today is our Director of Finance and Administration, Erika Gibson; our Chief Medical and Science Officer, Dr. Mike Rosol; and our Chief Compliance Officer and Regulatory Officer, Bill Regan.
Q1 2019 Navidea Biopharmaceuticals Inc Earnings Call Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers